Globus Medical, Inc. (GMED) stock analysis

GMED · Globus Medical, Inc.

Latest recorded price: USD 70.56

Model-estimated fair value: USD 91.83. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Devices

At $70.56, GMED trades 23.2% below the model's base-case value of $91.83. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $70.26 in the conservative case and $117.69 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 42.2%, free cash flow margin 20.0%, ROIC 9.3%. The model does not flag any risk signals for this company.

Similar companies in Healthcare